Adjuvant therapy for stage I testicular cancer

Cancer Treatment Reviews

Volumn 22, Issue 4, 1996, Pages 253-264

  Cullen, Michael ^a   James, Nicholas ^b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; ETOPOSIDE;

BONE MARROW SUPPRESSION; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; DRUG TOXICITY; GERM CELL TUMOR; HEALTH CARE POLICY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE DISSECTION; NAUSEA; PATIENT CARE; REVIEW; SEMINOMA; TESTIS CANCER; VOMITING;

EID: 0030455363     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-7372(96)90019-5     Document Type: Review

References (38)

1. Fossa, S. D. & Horwich, A. H. (1989) The staging and treatment of testicular cancer: Management of stage I disease. In: Smith, P. H., ed. Combination Therapy in Urological Malignancy. London: Springer Verlag, pp. 173-189.
2. Peckham, M. J., Barrett, A., Husband, J. E. & Hendry, W. F. (1982) Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumours. Lancet 11: 678-680.
3. Cullen, M. H. (1991) Management of Stage I non-seminoma: surveillance and chemotherapy. In: Horwich, A., ed. Testicular Cancer Investigation and Management. London: Chapman and Hall Medical, pp. 149-166.
4. Moynihan, C. (1987) Testicular cancer: the psychosocial problems of patients and their relatives. Cancer Surveys 6: 477-510.
5. Howard, G. C. W., Clarke, K., Elia, M. H. et al. (1995) A Scottish National Audit of current patterns of management for patients with testicular non-seminomatous germ cell tumours. Brit. J. Cancer 72: 1303-1306.
6. Vugrin, D., Peckham, M. J., Pizzocaro, G. et al. (1984) Multinational experience with orchidectomy alone in the treatment of clinical stage I nonseminomatus tumours. In: Jones, S.E. & Salmon, S.E., eds, Adjuvant Therapy of Cancer IV. Philadelphia: Grune & Stratton, pp. 521-527.
7. Sogani, P. C., Whitmore, W. F. Jr., Herr, H. W. et al. (1984) Orchidectomy alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis. J. Clin. Oncol. 2: 267-270.
8. McLeod, D. G., Weiss, R. B., Stablein, D. M. et al. for The Testicular Cancer Intergroup Study (1991) Staging relationships and outcome in early stage testicular cancer. A report from the Testicular Cancer Intergroup Study. J. Urol. 145: 1178-1183.
9. Freedman, L. S., Parkinson, M. C., Jones, W. G. et al. (1987) Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet 11: 294-298.
10. Read, G., Stenning, S. P., Cullen, M. H. et al. (1992) Medical Research Council Prospective study of surveillance for stage I testicular teratoma. J. Clin. Oncol. 10: 1762-1768.
11. Williams, S. D., Stablein, D. M., Einhorn, L. H. et al. (1987) Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. N. Engl. J. Med. 317: 1433-1438.
12. Stuart, N. S. A., Woodroffe, C. M., Grundy, R. & Cullen, M. H. (1990) Long-term side-effects of chemotherapy for testicular cancer: The cost of cure. Brit. J. Cancer 61: 479-484.
13. Cullen, M. H., Stenning, S. P., Parkinson, M. C. et al. (1996) Short course adjuvant chemotherapy in high risk stage 1 non-seminomatous germ cell tumours of the testis (NSGCTT): An MRC study report. J. Clin. Oncol. 14: 1106-1113.
14. Pont, J., Albrecht, W., Postner, G., Sellner, F., Angel, K. & Holtl, W. (1996) Adjuvant chemotherapy for high risk clinical stage I nonseminomatous testicular germ cell cancer: Long-term results of a prospective trial. J. Clin. Oncol. 14: 441-448.
15. Oliver, R. T. D., Raja, M. A., Ong, J. & Gallagher, C. J. (1992) Pilot study to evaluate impact of a policy of adjuvant chemotherapy for high risk stage I malignant teratoma on overall relapse rate of stage 1 cancer patients. J. Urol. 148: 1453-1456.
16. Studer, U. E., Fey, M. F., Calderoni, A., Kraft, R., Mazzucchelli, L. & Sonntag, R. W. (1993) Adjuvant chemotherapy after orchidectomy in high-risk patients with Clinical Stage I non- seminotous testicular cancer. Eur. Urol. 23: 444-449.
17. Cullen, M. H., Billingham, L., Cook, J. & Woodroffe, C. (1996) Management preferences in stage I non-seminomatous germ cell tumours of the testis: an investigation among patients controls and oncologists. Brit. J. Cancer (in press).
18. Horwich, A., Alsanjary, N., A'Hern, R. & Nicholls, J. (1992) Surveillance following orchidectomy for stage I testicular seminoma. Brit. J. Cancer 65: 775-778.
19. Von der Maase, H., Specht, L., Jacobsen, G. K. et al. (1993) Surveillance following orchidectomy for stage I seminoma of the testis. Eur. J. Cancer 29A: 1931-1934.
20. Warde, P. R., Gorpodarowicz, M. K., Goodman, P. J. et al. Results of a policy of surveillance in stage I testicular seminoma. Int. J. Radiat. Oncol. Biol. Phys. 27: 11-15.
21. Hamilton, C., Horwich, A., Easton, D. et al. (1986) Radiotherapy for stage I seminoma testis: Results of treatment and complications. Radiother. Oncol. 6: 115-120.
22. Fossa, S. D., Aass, N., Kaalhus, O. (1989) Radiotherapy for testicular seminoma stage I. Treatment results and long term post radiation morbidity in 365 patients. Int. J. Radiat. Oncol. Biol. Phys. 16: 383-388.
23. Oliver, R. T. D. (1987) Limitations to the use of surveillance as an option in the management of stage I seminoma. Int. J. Androl. 10: 263-268.
24. Fossa, S., Horwich, A., Russell, J. M., Roberts, J. P., Jakes, R. & Stenning, S. (1996) Optimal field size in adjuvant radiotherapy (XRT) of stage I seminoma - a randomised trial. Proc. Amer. Soc. Clin. One. 15: 239.
25. Read, G. & Johnston, R. J. (1993) Short duration radiotherapy in stage I seminoma of the testis: Preliminary results of a prospective study. Clin. Oncol. 5: 364-366.
26. Giacchetti, S., Raoul, Y., Wibault, P. et al. (1993) Treatment of stage I testis seminoma by radiotherapy: long-term results - a 30 year experience. Int. J. Rad. Oncol. Biol. Phys. 27: 3-9.
27. Ozen, H., Altug, N., Bakkaloglu, M.A. et al. (1988) Significance of scrotal violations in the prognosis of patients with testicular tumours. Br. J. Urol. 62: 267-270.
28. Oliver, R. T. D., Love, S. & Ong, J. (1990) Alternatives to radiotherapy in the management of seminoma. Br. J. Urol. 65: 61-67.
29. Schmoll, H. J., Harstrick, A., Bokenmeyer, C., et al. (1990) Single agent carboplatin for advanced seminoma - a phase II study. Cancer 72: 237-243.
30. Horwich, A., Mason, M. & Dearnaley, D. P. (1992) Use of carboplatin in germ cell tumours of the testis. Semin. Oncol. 19: 72-78.
31. Oliver, R. T. D., Edmonds, P. M., Ong, J. Y. H. et al. (1994) Pilot studies of 1 and 2 course carboplatin as adjuvant for stage I seminoma. Should it be tested in a randomised trial against radiotherapy? Int. J. Radiation Oncol. Biol. Phys. 29: 2-8.
32. Diekman, K. P., Kran, J., Kuster, J., Bruggeboes, B. (1994) Adjuvant carboplatintherapie beim seminom in klinischen stadium I. Z. Urol. Poster 1: 10-11.
33. Kratzik, C., Kuhrer, I., Wiltsche, C., Amman, G. (1993) Carboplatin-monotherapie bei seminomen in stadium 1. Acta. Chir. Aust. 25: 27-28.
34. Yao, W. Q., Fossa, S., Dearnaley, D. P., Horwich, A. (1994) Combined single course carboplatin with radiotherapy in treatment of Stage IIA, B seminoma. A preliminary report. Radiother. Oncol. 33: 88-90.
35. Read, G. (1994) Estimating the cost of radiotherapy. Clin. Oncol. 6: 35-39.
36. van Leeuwen, F. E. (1993) Second tumours after radiation treatment of testicular germ cell tumours. J. Clin. Oncol. 11: 2286-2287.
37. van Leeuwen, F. E., Stiggelbout, A. M. et al. (1993) Second cancer risk following testicular cancer: follow up on 1909 patients. . Clin. Oncol. 11: 415-424.
38. Aass, N., Fossa, S. D. & Host, H. (1992) Acute and subacute side effects due to infra-diaphragmatic radiotherapy for testicular cancer: a prospective study. Int. J. Radiat. Oncol. Biol. Phys. 22: 1057-1064.